NCT03285555

Brief Summary

The STRATAFIX (Ethicon, Johnson and Johnson, Somerville, New Jersey) Knotless Tissue Control suture device is a barbed suture that uses anchor technology to securely engage with the soft tissues while also eliminating the need for knots. The anchors, or barbs, are pressed out of the device core or formed within the core in a geometric pattern and arranged in a tapered manner to allow the device to pass through tissue in the direction toward the needle during closure. These knotless tissue control devices are deployed using a continuous technique, which is anticipated to be faster and more cost-effective than interrupted suturing.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 14, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 18, 2017

Completed
8 days until next milestone

Study Start

First participant enrolled

September 26, 2017

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2019

Completed
1 year until next milestone

Results Posted

Study results publicly available

September 4, 2020

Completed
Last Updated

November 17, 2020

Status Verified

October 1, 2020

Enrollment Period

1.8 years

First QC Date

September 14, 2017

Results QC Date

August 17, 2020

Last Update Submit

October 29, 2020

Conditions

Keywords

barbed sutureknoteless sutureclosurewoundtimetotal hip arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Time to Close, Minutes

    Time from first needle insertion to complete skin closure per protocol

    Day of surgery

Secondary Outcomes (1)

  • Number of Participants With Wound Complications

    90 days postoperative

Study Arms (2)

STRATAFIX GROUP

ACTIVE COMPARATOR

For the active arm of the study, wound closure will be performed similarly in 3 layers with the use of barbed equivalents at every layer: STRATIFIX symmetric PDS Plus #1 will be used to close the deep fascia and muscles . The subcutaneous fat layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl, Ethicon; Johnson \& Johnson) followed by the use of steri-strips and glue

Device: STRATIFIX

CONTROL GROUP

PLACEBO COMPARATOR

For the control arm of the study, wound closure will be performed similarly in 3 layers with the use of vicryl to closure the deep fascia and muscles. The subcutaneous fat layer will be then closed with simple interrupted knots using number 2-0 braided absorbable sutures (Vicryl), followed by closure of the subcutaneous layer using a number 2-0 monofilament absorbable suture with inverted interrupted knots (Monocryl, Ethicon; Johnson \& Johnson) followed by the use of steri-strips and glue

Device: VICRYL

Interventions

STRATIFIXDEVICE

STRATIFIX symmetric PDS Plus; Stratifix knotless suture

STRATAFIX GROUP
VICRYLDEVICE

Vicryl #1

CONTROL GROUP

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males and females, between the ages of 18 to 80 years at the time of signing the informed consent document.
  • Understand and voluntarily sign an informed consent document prior to any study-related assessments/procedures are conducted.
  • Able to adhere to the study visit schedule and other protocol requirements.
  • Able to fluently speak and understand the local language
  • If female, is non-pregnant (negative pregnancy test results at the baseline/randomization visit) and non-lactating.
  • End-stage osteoarthritis patients planning to undergo primary total hip arthroplasty
  • BMI less than 40 kg/m2

You may not qualify if:

  • BMI greater than or equal to 40 kg/m2.
  • History of known bleeding disorder.
  • History of medical co-morbidity that may result in poor wound healing (i.e. diabetes mellitus, peripheral vascular disease).
  • Patients \<18 or \>80 years of age.
  • Patients who are prisoners.
  • Mentally unable to sign informed consent.
  • Has an uncontrolled illness that, in the opinion of the investigator, is likely to cause the patient to be withdrawn from the trial or would otherwise interfere with interpreting the results of the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic

Cleveland, Ohio, 44195, United States

Location

Related Publications (1)

  • Sundaram K, Piuzzi NS, Klika AK, Molloy RM, Higuera-Rueda CA, Krebs VE, Mont MA. Barbed sutures reduce arthrotomy closure duration and suture utilisation compared to interrupted conventional sutures for primary total hip arthroplasty: a randomised controlled trial. Hip Int. 2021 Sep;31(5):582-588. doi: 10.1177/1120700020911891. Epub 2020 Mar 19.

MeSH Terms

Conditions

Wounds and Injuries

Results Point of Contact

Title
Viktor Krebs
Organization
Cleveland Clinic

Study Officials

  • Viktor Krebs

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Vice Chairman - Adult Reconstruction

Study Record Dates

First Submitted

September 14, 2017

First Posted

September 18, 2017

Study Start

September 26, 2017

Primary Completion

June 30, 2019

Study Completion

August 31, 2019

Last Updated

November 17, 2020

Results First Posted

September 4, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

No data will be shared with other researchers.

Locations